|
CAS-Nr. | 114041-00-8 |
Bezeichnung: | |
Englisch Name: | 4-(4-(DIHEXADECYLAMINO)STYRYL)-N-METHYLPYRIDINIUM IODIDE |
Synonyma: | DIA;CDF;DRF2;Diasp;DIAPH2;DIA IODIDE;4-DI-16-ASP IODIDE;Diaphanous-related formin-2;Protein diaphanous homolog 2;Anti-LIF antibody produced in goat |
CBNumber: | CB7272385 |
Summenformel: | C46H79IN2 |
Molgewicht: | 787.04 |
MOL-Datei: | 114041-00-8.mol |
|
|
|
|
4-(4-(DIHEXADECYLAMINO)STYRYL)-N-METHYLPYRIDINIUM IODIDE physikalisch-chemischer Eigenschaften |
|
4-(4-(DIHEXADECYLAMINO)STYRYL)-N-METHYLPYRIDINIUM IODIDE Chemische Eigenschaften,Einsatz,Produktion Methoden |
|
4-(4-(DIHEXADECYLAMINO)STYRYL)-N-METHYLPYRIDINIUM IODIDE Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
4-(4-(DIHEXADECYLAMINO)STYRYL)-N-METHYLPYRIDINIUM IODIDE Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 14)Lieferanten |
|
|
|
|
114041-00-8(4-(4-(DIHEXADECYLAMINO)STYRYL)-N-METHYLPYRIDINIUM IODIDE)Verwandte Suche: |
N-Methyldidodecylamin
N,N-Dibutylanilin
N-dodecyl-N-methylanilin
4-Styrylpyridin
|
PYRIDINIUM, 4-[2-[4-(DIHEXADECYLAMINO)PHENYL]ETHENYL]-1-METHYL-, IODIDE
4-((E)-2-[4-(DIHEXADECYLAMINO)PHENYL]ETHENYL)-1-METHYLPYRIDINIUM IODIDE
4-DI-16-ASP IODIDE
4-(P-DIHEXADECYLAMINOSTYRYL)-N-METHYLPYRIDINIUM IODIDE
4-(4-(DIHEXADECYLAMINO)STYRYL)-N-METHYLPYRIDINIUM IODIDE
114041-00-8
DIA
DIA IODIDE
4-(P-dihexadecylaminostyryl)-N-*methylpyridinium
4-(P-DIHEXADECYLAMINOSTYRYL)-N-METHYLPYR IDINIUM IO
4-(4-dihexadecylaminostyryl)-N-methylpyridium
4-[2-[4-(Bishexadecylamino)phenyl]ethenyl]-1-methylpyridinium iodide
C46H79N2I
4-(2-(4-(Dihexadecylamino)phenyl)ethenyl)-1-methylpyridinium iodide
4-(4-Dihexadecylaminostyryl)N-methylpyridium, iodide
Diasp
4-(4-(DihexadecylaMino)styryl)-N-MethylpyridiniuM iodide, DiADiA
ANTI-DIAPH2 (CENTER) antibody produced in rabbit
DIAPH2
Diaphanous-related formin-2
DRF2
Protein diaphanous homolog 2
Anti-LIF antibody produced in goat
CDF
leukemia inhibitory factor (cholinergic differentiation factor)
|
Urheberrecht 2009 © ChemicalBook. Alle Rechte vorbehalten. |